Karin L.
- Country
- Sweden
- Department
- Hematologi Mottagning
Research Overview
Data & Insights
Has run more than one trial at 0 of 51 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating relapsed and refractory multiple myeloma, with particular focus on innovative therapeutic approaches for plasma cell disorders.
- Multiple Myeloma Treatment
- Plasma Cell Disorders
- Hematologic Malignancies
Areas of interest include advanced treatment modalities for patients with recurring plasma cell myeloma.
Drug Administration Methods
The investigator focuses on comparing different administration routes for targeted therapies, particularly examining subcutaneous versus intravenous delivery methods.
- Drug Delivery Systems
- Treatment Administration
- Therapeutic Efficacy
Expertise includes evaluating treatment administration methods to optimize patient outcomes.
Combination Therapy
The investigator explores multi-drug therapeutic approaches in hematologic oncology, focusing on combination treatments for enhanced efficacy.
- Drug Combinations
- Treatment Optimization
- Clinical Outcomes
Interest extends to developing effective combination strategies for resistant disease forms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.